Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Acute pancreatitis followed by leukocytoclastic vasculitis induced by tirzepatide: A first case report with this new medication
Therapie, 2026
Oral Adverse Effects of Semaglutide Therapy: A Narrative Review
Journal of International Society of Preventive & Community Dentistry, 2026;16(4):331-340
GLP-1 and MASH: When weight loss isn’t the whole story
Cell metabolism;38(7):1258-1260
Real-World vs. Randomized Trial Evidence for Incretin-Based Therapies: A Narrative Review
Journal of diabetes;18(7):e70248
Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics: A Systematic Review and Network Meta-Analysis
JAMA psychiatry, 2026
Disrupting the adiposopathy-inflammation loop: a translational immunometabolic framework for inflammatory disease
Journal of translational medicine, 2026
Comparative effectiveness of tirzepatide and DPP-4 inhibitors in type 2 diabetes with heart failure
Diabetes & vascular disease research, 2026;23(4):14791641261467888
Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists
Diabetes, obesity & metabolism, 2026
Real-World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes
Diabetes, obesity & metabolism, 2026
Short-Term HbA1c Non-Inferiority of Synthetic Semaglutide Should Not Be Conflated With Full Therapeutic Interchangeability
Diabetes, obesity & metabolism, 2026
Glucagon-like peptide-1 receptor agonists for weight management in mental illness: a network meta-analysis
Translational psychiatry, 2026
Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis
BMJ (Clinical research ed.), 2026;394:e372161
The Neuroendocrine-Appetite-Mental Health Triangle in PMOS: Implications for GLP-1 Receptor Agonist Therapy
Neuroscience and biobehavioral reviews, 2026;:106846
GLP-1R and GIPR crosstalk modulates insulinotropic signaling pathways
Cell chemical biology, 2026
Effects of tirzepatide therapy on body weight and body composition in adults with overweight and obesity
Frontiers in endocrinology, 2026;17:1834580
Personalization of incretin therapy: can GLP-1 and GIP receptor polymorphisms influence therapy response?
Journal of the Endocrine Society, 2026;10(8):bvag149
Incretin-Based Therapies in Sports: Pharmacological Mechanisms, Performance-Enhancing Potential, and Anti-Doping Implications-A Narrative Review
International journal of molecular sciences, 2026;27(14)
A tea exosome-integrated self‑oxygenating cascade chitosan/oxidized alginate hydrogel for remodeling the hyperglycemic and hypoxic microenvironment in diabetic wound healing
Carbohydrate polymers, 2026;389:125628
Semaglutide Modulates Visceral Adipose Tissue Lipid Metabolism in Type 2 Diabetic Mice: A Lipidomics Study
Frontiers in bioscience (Landmark edition);31(6):49873
Harnessing the Reactivity of Sulfinate Salts With Cystine: An Umpolung Approach to Residue-Specific Peptide Modification
Angewandte Chemie (International ed. in English), 2026;:e5484068